Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

El.En. Investor Presentation 2018

May 16, 2018

4393_cp_2018-05-16_88fb12f0-8292-49b9-b233-6df5eaa9900f.pdf

Investor Presentation

Open in viewer

Opens in your device viewer

COMPANYPRESENTATION

Paris - May 17th, 2018

DISCLAIMER

Certain statements in this slide show, including those addressing the Company's beliefs, plans, objectives, estimates or expectations of possible future results or events, are forward‐looking statements. Forward‐looking statements involve known or unknown risks, including general economic and business conditions, and conditions in the industry we operate and may be affected should our assumptions turn out to be inaccurate. Consequently, no forward‐looking statement can be guaranteed and actual future results, performance, or achievements may vary materially from those expressed or implied by such forward‐looking statements. The Company undertakes no obligation about the contents nor to update the forward‐looking statements to reflect events or circumstances that may arise after the date hereof.

AGENDA

El.En.

A Primary Player Providing Medical, Industrial, and Conservation Laser Solutions Worldwide

Hi‐Tech company

Hi‐Tech industrial group active in opto‐electronics with proprietary technologies and know how developed over 35 years

International Group

More than 20 companies active worldwide on several markets and application segments. Listed on the Milan Stock Exchange, Star segment since 2000

Among the leaders in the global market

Progressively widening its worldwide presence registering continuous growth over the years

Worldwide distribution network

1,300 employees worldwide; 38 years average age

More than 40,000 laser sources sold and 5% of revenue invested in R&D

Constant and sustainable growth

14% Revenue CAGR 2011 – 2017

35% EBIT CAGR 2011 – 2017

FY 2017 Consolidated Revenue: €306m, up 21% YoY

Apath of growth

in Euro million

OurMarkets

Medical & Aesth energy ‐based systems market

\$
i
l
l
i
U
S
m
o
n		 2
0
1
4		 2
0
1
6		 2
0
2
1		 C
A
G
R		 C
A
G
R
1
4‐
1
6		 1
6‐
2
1
l
b
l
d
l
l
G
i
i
i
i
o
a
n
o
n‐
n
a
s
e
a
n
m
n
m
a
v
v
y
l
h
i
i
d
i
i
t
t
t
t
t
n
v
a
s
v
e
m
e
c
a
a
e
s
e
c
r
e
a
m
e
n
t
s
y
s
e
m
s		 6.
9
3
2		 8.
4
3
7		 1
3.
9
9
2		 %
1
0		 %
1
1
b
d
E
t
t
t
t
n
e
r
g
y
a
s
e
r
e
a
m
e
n
s
y
s
e
m
s
‐		 2.
0
3
3		 2.
6
7
0		 4.
3
8
0		 %
1
5		 %
1
0
d
h
i
&
k
i
i
h
i
B
S
t
t
o
y
s
a
p
n
g
n
g
e
n
n
g		 7
2
4		 9
9
6		 1.
9
6
5		 %
1
7		 %
1
5
k
S
i
j
i
t
n
r
e
u
v
e
n
a
o
n		 5
2
3		 6
9
5		 1.
0
8
9		 %
1
5		 %
9
l
H
i
a
r
r
e
m
o
v
a		 3
5
3		 3
4
1		 3
3
3		 2
%
‐		 0
%
L
i
t
t
t
e
g
v
e
n
r
e
a
m
e
n
s		 1
3
1		 1
5
7		 1
8
7		 9
%		 4
%
d
A
i
t
c
n
e
r
e
u
c
o
n		 9
6		 1
1
0		 1
2
5		 %
7		 3
%
l
i
j
i
V
t
a
g
n
a
r
e
e
n
a
o
n
u
v		 n
a		 0
1
5		 3
3
2		 n
a		 2
6
%
d
l
l
i
i
&
P
t
t
t
t
g
m
e
n
e
e
s
o
n
a
o
o
r
e
m
o
v
a		 8
0		 9
9		 1
4
2		 %
1
1		 %
7
h
O
t
e
r		 1
2
6		 1
6
7		 2
0
7		 1
5
%		 4
%
l
T
t
o
a		 2.
0
3
3		 2.
6
7
0		 4.
3
8
0		 1
5
%		 1
0
%

Source: Medical Insight Report

Key growth drivers:

  • Increasingly aging population
  • Desire to achieve or maintain more youthful appearance
  • Increase in healthcare spending
  • Requirements for fast and minimally invasive surgical procedure s

Industriallaser market

Lasers increasingly adopted in high quality manufacturing for uniqueness, flexibility, environment friendliness, productivity

  • •Sheet metal cutting: technology breakthroughs lead to strong widening of demand
  • •Laser marking for identification: traceability as a quality standard

MARKET STUDIES:

Technavio's analysts forecast :"The global industrial laser market to grow at a CAGR of 10.24% during the period 2017‐2021"

Growthdrivers

Growth drivers

  • Expected growth in our main markets: Aesthetic , Surgery, Industrial
  • Entering the body contouring and cellulite treatment market
  • Novel dermatologic treatment device: 2019
  • Hologic/ Cynosure focused again on Mona Lisa Touch
  • Diabetic foot ulcers: seeking regulatory clearances worldwide
  • New applications for medium power CO2 laser sources
  • Strong demand for high power laser sheet metal cutting systems in China and Europe

Newsystems and devices

  • ONDA ‐ Body contouring
  • Motus AX expands to Motus AY
  • BPH: Virtual basket and single use morcellator
  • PicoStar ‐ Asclepion launched the most powerful Picolaser
  • High Power sheet metal cutting systems ‐ 15kW
  • OEM systems for urology

Newfactories

Jena

FinancialHighlights

Income statement FY ‐2017

l
l
i
i
E
M
u
r
o
o
n		 /
/
3
1
1
2
1
6		 % /
/
3
1
1
2
1
7		 % %
V
a
r.
d
l
i
M
e
c
a		 1
6
6
0
6
5		 6
%
5
7
,		 1
4
4
1
6
7		 6
9
%
5
,		 0
%
5
,
d
l
I
i
t
n
u
s
r
a		 8
6
5
9
0		 %
3
4
3
,		 1
3
2
0
4
5		 %
4
3
1
,		 %
5
2
5
,
l
T
R
t
o
a
e
v
e
n
u
e
s		 2
2
6
6
5
4		 0
0
0
%
1
,		 3
0
6
6
4
1		 0
0
0
%
1
,		 2
3
%
1,
G
i
r
o
s
s
m
a
r
g
n		 1
1
0
3
3
5		 4
3
8
%
,		 1
2
2
8
4
7		 4
1,
%
5		 1
2
%
5
,
E
B
I
T
D
A		 3
2
3
8
8		 %
1
2
8
,		 3
6
1
2
5		 %
1
1,
8		 %
1
1,
5
E
B
I
T		 2
7
5
9
4		 %
1
0
9
,		 3
0
4
4
9		 %
9
9
,		 %
1
0
3
,
P
I
t
r
e
a
x
n
c
o
m
e		 2
2
5
7
1		 2
0
9
%
,		 2
2
7
1
7		 8
9
%
,		 8
%
4
4
‐
,
N
i
t
e
n
c
o
m
e		 4
0
4
0
8		 1
6
0
%
,		 1
6
3
4
5		 1
%
5
,		 6
1,
3
%
‐
h
N
I
t
e
n
c
o
m
e
p
e
r
s
a
r
e		 2
0
9
,		 0
8
1
,

Balancesheet‐2017

l
l
i
i
E
M
u
r
o
o
n		 /
/
3
2
6
1
1
1		 /
/
3
2
1
1
1
7		 %
V
a
r.
l
T
t
t
t
o
a
n
o
n
c
u
r
r
e
n
a
s
s
e
s		 6
4
7
3
7		 6
5
6
6
4		 1,
4
%
k
l
N
W
i
C
i
t
t
e
o
r
n
g
a
p
a		 5
4
1
6
0		 6
3
6
2
2		 %
1
7
5
,
f
l
i
i
i
i
N
t
t
e
n
a
n
c
a
p
o
s
o
n		 8
2
7
8
4		 8
4
5
0
6		 %
2
1
,
l
b
l
i
i
i
i
L
t
t
o
n
g
e
r
m
a
e
s		 8
9
8
2		 9
4
9
6		 %
5
7
,
i
N
E
t
t
e
q
u
y		 9
2
6
9
9
1		 2
0
2
9
6
4		 6
0
%
,
l
l
d
i
N
t
t
e
c
a
p
a
e
m
p
o
y
e		 1
0
9
9
1
5		 1
1
9
9
0
7		 9
0
%
,
k
l
l
N
W
i
C
i
t
t
e
o
r
n
g
a
p
a
o
n
s
a
e
s		 2
1,
4
%		 2
0
8
%
,
R
O
C
E		 %
2
5
1
,		 %
2
5
4
,
/
(
)
l
l
d
i
E
B
I
T
N
t
t
e
c
a
p
a
e
m
p
o
e
y
C
a
p
e
x		 1
1
4
4
1		 8
5
1
5

Income statement Q1 ‐2018

l
l
i
i
E
M
u
r
o
o
n		 /
/
%
3
1
0
3
1
7		 /
/
3
1
0
3
1
8		 % %
V
a
r.
d
d
i
t
u
n
a
u
e		 d
d
i
t
u
n
a
u
e
d
l
i
M
e
c
a		 3
9
0
3
5		 6
0,
0
%		 4
1
0
6
7		 6
0,
0
%		 6,
8
%
d
l
i
I
t
n
u
s
r
a		 2
6
0
5
5		 0,
0
%
4		 2
8
6
7
4		 0,
0
%
4		 6,
9
%
l
T
R
t
o
a
e
e
n
e
s
v
u		 6
1
0
5
7		 1
0
0,
0
%		 6
9
2
5
5		 1
0
0,
0
%		 6,
8
%
G
i
r
o
s
s
m
a
r
g
n		 2
6
9
2
3		 %
4
1,
4		 2
9
6
2
7		 2,
%
4
7		 0,
2
%
1
E
B
I
T
D
A		 6
5
3
9		 %
1
0,
0		 6
4
2
7		 %
9,
2		 %
1,
7
‐
E
B
I
T		 5
5
3
2		 %
8,
5		 5
3
4
8		 %
7,
7		 %
3,
3
‐
P
I
t
r
e
a
n
c
o
m
e
x		 5
1
7
0		 7,
9
%		 4
6
2
7		 6,
7
%		 1
0,
5
%
‐
/
/
3
1
1
2
1
7		 /
/
3
1
0
3
1
8
d
d
i
t
u
n
a
u
e
f
l
i
i
i
i
N
t
t
e
n
a
n
c
a
p
o
s
o
n		 8
4
5
0
6		 7
2
5
7
3

Revenuebreakdown Q1‐2018

Revenuebreakdown Q1‐2018

Guidance

Multiples &Comparables

Multiples

k
h
l
d
's
h
S
i
E
t
t
o
c
o
e
r
q
u
y
p
e
r
s
a
r
e		 9,
9
/
i
k
l
d
j.
P
B
V
A
r
c
e
o
o
a
u
e		 3,
0
/
(
)
8
0
%
E
V
E
B
I
T
E
B
I
T		 2
8,
9
/
(
)
l
l
E
V
S
8
0
%
S
a
e
s
a
e
s		 2,
2
l.
k
E
E
M
C
t
n.
a
r
e
a
p.		 @
5
7
8,
9		 €
3
0,
0
0
f
i
i
l
i
i
N
t
t
e
n
a
n
c
a
p
o
s
o
n		 @
7
2,
6		 /
/
3
1
0
3
1
8
/
l
l
i
i
i
F
t
t
t
n
a
n
c
a
n
e
s
m
e
n
s
m
e
r
m
v		 @
1
2,
1		 /
/
3
1
0
3
1
8

Comparables

in m
Am
nts
ou		 ln
M
3
1s
2
0
1
8
t,
ar		 k
/
l
he
d
ica
ic
M
Ae
t
t
e
s		 ice
Pr		 Re
ve
nu
e		 %
Va
r.
Re
v.		 E
B
I
T		 %
E
B
I
T		 M
K.
Ca
p.		 E
V		 /
les
E
V
Sa
(
*)		 /
E
V
E
B
I
T
(
*)		 /
P
Bo
o
lue
Va
Cu
te
ra		 \$
3
7,
4
5		 \$
3
4		 1
6
%		 \$
(
)
5		 1
4
%
‐		 \$
4
8
3		 \$
4
5
9		 3,
4		 n.a 7,
1
io
las
B
e		 \$
1,
4
5		 \$
0
1		 8
%
‐		 \$
(
)
5		 2
%
5
‐		 \$
3
0		 \$
2
4		 0,
6		 n.a 2
1,
d
l
(
**
)
S
isr
M
ica
am
e		 \$
0,
8
1		 \$
1
3
7		 1
6
%		 \$
2
1		 1
5
%		 \$
3
5
7		 \$
2
6
4		 1,
9		 1
2,
5		 1,
2
du
ia
l
In
tr
s
ho
I
P
G
P
ics
Co
to
n		 \$
2
5
2,
9
8		 \$
3
6
0		 2
6
%		 \$
1
4
1		 3
9
%		 \$
1
3.
5
7
0		 \$
1
2.
3
9
8		 8,
6		 2
2,
0		 6,
3
im
du
ie
Pr
In
tr
a
s		 €
3
8,
8
5		 €
9
6		 %
7		 €
2		 %
2		 €
3
9
9		 €
4
8
4		 1,
3		 5
3,
9		 2,
6
's
Ha
La
n
se
r		 2,
9
¥
5
7		 1.
6
9
2
¥		 1
1
%		 1
0
¥
7		 1
0
%		 6.
3
3
0
¥
5		 3.
8
3
¥
5
4		 8,
0		 9,
2
7		 2
7,
l.
(
)
E
En
1		 €
3
0,
0
0		 €
7
0		 7
%		 €
5		 8
%		 €
5
7
9		 €
4
9
4		 2,
2		 2
8,
9		 3,
0

(*) Revenue,Ebit and earnings annualized

(**) Data as at Dec. 31st 2017

Contacts

El.En. SPA

Enrico ROMAGNOLI Investor Relations Manager tel. +39 055‐8826807E‐mail: [email protected]

POLYTEMS HIR

Financial Communication, IR and Press Office Bianca FERSINI MASTELLONI ‐ [email protected] [email protected] Tel. +39 06‐69923324

More from El.En.

Interim / Quarterly Report 2026
May 26
Governance Information 2026
May 26
AGM Information 2026
May 26
Report Publication Announcement 2026
May 26
Report Publication Announcement 2026
May 26
Investor Presentation 2026
May 18
Investor Presentation 2026
May 18
Report Publication Announcement 2026
May 18
Investor Presentation 2026
May 18
Report Publication Announcement 2026
May 18
View all filings →